Benefits include reduction in falls and cognitive impairment and improvements in life expectancy, quality of life
MONDAY, Nov. 3, 2025 (HealthDay News) — Reducing future use of sleep medications could help older adults live healthier lives with fewer limitations, according to a study published online Oct. 24 in The Lancet Regional Health — Americas.
Hanke Heun-Johnson, from University of Southern California (USC) in Los Angeles, and colleagues estimated the remaining lifetime burden of sleep medication for U.S. adults older than 50 years. The Future Elderly Model microsimulation used data from the Health and Retirement Study (1998 to 2018).
The researchers found that by avoiding future sleep medication use in the 15.3 million Americans older than 50 years regularly using these drugs, the lifetime incidence of falls decreased by 8.5 percent and cognitive impairment decreased by 2.1 percent. Additionally, life expectancy increased by 0.11 years. Eliminating future use collectively could save 1.7 million life years and 1.3 million quality-adjusted life years. The net lifetime economic savings was estimated to be $6,600 per person and $101 billion in the United States. Improved quality of life accounted for the largest share.
“Insomnia is a serious issue for many older adults, but regular use of sleep medication can pose real risks. Supporting physicians in reducing prescriptions and promoting safer, proven alternatives will ultimately benefit patients and society,” coauthor Jason Doctor, also from USC, said in a statement.
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL
Mortality Lowest at Hemoglobin Concentrations Above WHO Thresholds
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors
Recommendations Updated for Management of Anemia in CKD
More Advanced CKM Syndrome Linked to Worse Cardiovascular Health
Preoperative IV Iron Beneficial for Patients With Anemia Undergoing Cardiac Surgery
Azacitidine + Venetoclax Tied to Improved Event-Free Survival in Adults With AML
2011 to 2021 Saw Heart Failure-Related Hospitalization Rise in CKD